Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-09T12:45:08.471Z Has data issue: false hasContentIssue false
  • English
  • Français

Toward a Biochemical Classification of Depressive Disorders IX

DST Results and Platelet MAO Activity

Published online by Cambridge University Press:  29 January 2018

Alan F. Schatzberg ,
Anthony J. Rothschild ,
Benjamin Gerson ,
Jan E. Lerbinger  and
Joseph J. Schildkraut
Alan F. Schatzberg*
Affiliation:
Affective Disease Program, McLean Hospital, Belmont, MA 02178
Anthony J. Rothschild
Affiliation:
Harvard Medical School and Affective Disease Program, McLean Hospital
Benjamin Gerson
Affiliation:
Harvard Medical School; Psychiatric Chemistry Laboratory, New England Deaconess Hospital
Jan E. Lerbinger
Affiliation:
Affective Disease Program, McLean Hospital
Joseph J. Schildkraut
Affiliation:
Harvard Medical School; Neuropsychopharmocology Laboratory, Massachusetts Mental Health Center; and Psychiatric Chemistry Laboratory, New England Deaconess Hospital
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Summary

Post-dexamethasone cortisol and platelet monoamine oxidase (MAO) activity levels were examined in 50 depressed patients. The incidence of non-suppression was significantly greater in patients with high platelet MAO activity than in those with low activity. Similar results were obtained when males and females were analysed separately. The mean 4 p.m. post-dexamethasone cortisol level was significantly higher in those patients who had high MAO activity than in their low MAO counterparts. Moreover, a statistically significant positive correlation was observed between platelet MAO activity and 4 p.m. post-dexamethasone cortisol levels.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 146 , Issue 6 , June 1985 , pp. 633 - 637
Copyright
Copyright © 1985 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agren, H. & Oreland, L. (1982) Early morning awakening in unipolar depressives with higher levels of platelet MAO activity. Psychiatry Research, 7, 245–254.Google Scholar
Asnis, G. M., Sachar, E. J., Halbreich, U., Nathan, R. S., Novacenko, H. & Ostrow, L. (1981) Cortisol secretion in relation to age in major depression. Psychosomatic Medicine, 43, 235–242.Google Scholar
Brown, W. A., Johnson, R. & Mayfield, D. (1979) The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms, and response to treatment. American Journal of Psychiatry, 136, 543–547.Google Scholar
Carroll, B. J., Curtis, G. D. & Mendels, J. (1976) Neuroendocrine regulation in depression. Archives of General Psychiatry, 33, 1051–1058.Google Scholar
Vigne, J. P. Feinberg, M., Greden, J. F., Tarika, J., Albala, A. A., Haskett, R. F., McIjames, N., Kronfol, Z., Lohr, N., Steiner, M., de Vigne, J. P. & Young, E. (1981) A specific laboratory test for the diagnosis of melancholia. Archives of General Psychiatry, 38, 15–22.Google Scholar
Corash, L., Tan, H. & Gralnick, H. R. (1977) Heterogeneity of human whole blood platelet subpopulations. I. Relationships between buoyant density, cell volume, and ultrastructure. Blood, 49, 71–87.Google Scholar
Edelstein, C. K. Roy-Byrne, P., Fawzy, F. I. & Dornfeld, L. (1983) Effects of weight loss on dexamethasone suppression test. American Journal of Psychiatry, 140, 338–341.Google Scholar
Gudeman, J. E., Schatzberg, A. F., Samson, J. A., Orsulak, P. J., Cole, J. O. & Schildkraut, J. J. (1982) Toward a biochemical classification of depressive disorders, VI: platelet MAO activity and clinical symptoms in depressed patients. American Journal of Psychiatry, 139, 630–633.Google Scholar
Haier, R. J., Buchsbaum, M. S., Murphy, D. L., Gottesman, I. I. & Coursey, L. D. (1980) Psychiatric vulnerability, monoamine oxidase and the averaged evoked potential. Archives of General Psychiatry, 37, 340–345.CrossRefGoogle Scholar
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry, 23, 56–62.Google Scholar
Jimerson, D. C., Insel, T. R., Reus, V. I. & Kopin, I. J. (1983) Increased plasma MHPG in dexamethasone - resistant depressed patients. Archives of General Psychiatry, 40, 173–176.CrossRefGoogle ScholarPubMed
Mann, J. (1979) Altered platelet monoamine oxidase activity in affective disorders. Psychological Medicine, 9, 729–736.Google Scholar
Mooney, J. J., Chao, F. C., Orsulak, P. J., Adler, S. A. & Schildkraut, J. J. (1981) Platelet monoamine oxidase activity in psychiatric disorders: the application of the technique for the isolation of free platelet mitochondria from relatively small blood samples, Journal of Psychiatric Research, 16, 163–171.Google Scholar
Murphy, D. L. & Weiss, R. (1972) Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. American Journal of Psychiatry, 128, 1351–1357.Google Scholar
Orsulak, P. J., Schildkraut, J. J., Schatzberg, A. F. & Herzog, J. M. (1978) Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Biological Psychiatry, 13, 637–647.Google Scholar
Reus, V. I. (1982) Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms. Biological Psychiatry, 17, 317–326.Google Scholar
Robinson, D. S., Nies, A., Lamborn, K. R., Ravaris, C. L. & Ives, J. O. (1975) Patterns of monoamine oxidase activity in man. In Neuropsychopharmacology. Excerpta Medica International Congress #359. Amsterdam, P 989–993.Google Scholar
Robinson, D. S., Davis, J. M., Nies, A., Ravaris, C. L. & Sylvester, D. (1971) Relaxation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets. Archives General Psychiatry, 24, 536–539.CrossRefGoogle Scholar
Robinson, D. S. & Nies, A. (1980) Demographic, biologic, and other variables affecting monoamine oxidase activity. Schizophrenia Bulletin, 6, 298–307.Google Scholar
Rosenbaum, A. H., Maruta, T., Schatzberg, A. F., Orsulak, P. J., Jiang, N-S., Cole, J. O. & Schildkraut, J. J. (1983) Toward a biochemical classification of depressive disorders. VII: urinary free Cortisol and urinary MHPG in depressions. American Journal of Psychiatry, 140, 314–318.Google Scholar
Rothschild, A. J., Langlais, P. J., Schatzberg, A. F., Walsh, F. X., Cole, J. O. and Bird, E. D. (1984) Dexamethasone increases plasma free dopamine in man. Journal of Psychiatric Research, 18, 217–223.Google Scholar
Sachar, E. J., Asnis, G., Nathan, S., Halbreich, U., Tabrizzi, M. A. & Halpern, F. S. (1980) Dextroamphetamine and Cortisol in depression: morning plasma Cortisol suppressed. Archives of General Psychiatry, 37, 755–757.CrossRefGoogle ScholarPubMed
Schatzberg, A. F., Rothschild, A. J., Stahl, J. B., Bond, T. C., Rosenbaum, A. H., Lofgren, S. B., MacLaughun, R. A. & Sullivan, M. A. (1983a) The dexamethasone suppression test: identification of subtypes of depression. American Journal of Psychiatry, 140, 88–91.Google Scholar
Schatzberg, A. F., Orsulak, P. J., Rothschild, A. J., Salomon, M. S., Lerbinger, J., Kizuka, P. P., Cole, J. O. & Schildkraut, J. J. (1983b) Platelet MAO activity and the dexamethasone suppression test in depressed patients. American Journal of Psychiatry, 140, 1231–1233.Google Scholar
Schildkraut, J. J. (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. American Journal of Psychiatry, 122, 509–522.Google Scholar
Spitzer, R. L., Endicott, J. & Robins, E. (1978) Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry, 35, 773–782.CrossRefGoogle ScholarPubMed
Stokes, P. E., Frazer, A. & Casper, R. (1981) Unexpected neuroendocrine-transmitter relationships. Psychopharmocology Bulletin, 17, 72–75.Google Scholar
Tarver, J., Berkowttz, B. & Spector, S. (1973) Alterations in tyrosine hydroxylase and monoamine oxidase activity in blood vessels. Nature, 231, 252–253.Google Scholar
Touringy-Rivard, M. F., Raskind, M. & Rivard, D. (1981) The dexamethasone suppression test in an elderly population. Biological Psychiatry, 16, 1177–1184.Google Scholar
Young, J. G., Cohen, D. J., Waldo, M. C., Feiz, R. & Roth, J. A. (1980) Platelet monoamine oxidase activity in children and adolescents with psychiatric disorders. Schizophrenia Bulletin, 6, 324–333.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.